Hansoh Pharmaceutical Group Co Ltd (3692)

Hong Kong
Currency in HKD
29.20
-0.10(-0.34%)
Delayed Data·
3692 Scorecard
Full Analysis
Has a perfect Piotroski Score of 9
3692 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
28.7529.75
52 wk Range
15.3230.85
Key Statistics
Edit
Bid/Ask
29.10 / 29.20
Prev. Close
29.3
Open
29.75
Day's Range
28.75-29.75
52 wk Range
15.32-30.85
Volume
1.71M
Average Volume (3m)
13.13M
1-Year Change
66.86%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
3692 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
28.52
Downside
-2.32%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet
Show more

Hansoh Pharmaceutical Group Co Ltd Company Profile

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.

Employees
8989
Market
Hong Kong

Compare 3692 to Peers and Sector

Metrics to compare
3692
Peers
Sector
Relationship
P/E Ratio
36.5x30.9x−0.5x
PEG Ratio
0.900.070.00
Price/Book
5.6x2.2x2.6x
Price / LTM Sales
13.0x3.3x3.1x
Upside (Analyst Target)
−1.0%23.8%48.6%
Fair Value Upside
Unlock1.3%8.9%Unlock

Analyst Ratings

23 Buy
1 Hold
1 Sell
Ratings:
25 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 28.52
(-2.32% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.74%
Dividend Yield
1.14%
Industry Median 2.84%
Annualised payout
0.34
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Mar 21, 2025
EPS / Forecast
0.28 / 0.65
Revenue / Forecast
5.76B / --
EPS Revisions
Last 90 days

3692 Income Statement

FAQ

What Is the Hansoh Pharmaceutical Group (3692) Stock Price Today?

The Hansoh Pharmaceutical Group stock price today is 29.20

What Stock Exchange Does Hansoh Pharmaceutical Group Trade On?

Hansoh Pharmaceutical Group is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Hansoh Pharmaceutical Group?

The stock symbol for Hansoh Pharmaceutical Group is "3692."

Does Hansoh Pharmaceutical Group Pay Dividends? What’s The Current Dividend Yield?

The Hansoh Pharmaceutical Group dividend yield is 1.15%.

What Is the Hansoh Pharmaceutical Group Market Cap?

As of today, Hansoh Pharmaceutical Group market cap is 174.21B.

What Is Hansoh Pharmaceutical Group's Earnings Per Share (TTM)?

The Hansoh Pharmaceutical Group EPS (TTM) is 0.74.

From a Technical Analysis Perspective, Is 3692 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Hansoh Pharmaceutical Group Stock Split?

Hansoh Pharmaceutical Group has split 0 times.

How Many Employees Does Hansoh Pharmaceutical Group Have?

Hansoh Pharmaceutical Group has 8989 employees.

What is the current trading status of Hansoh Pharmaceutical Group (3692)?

As of 17 Jun 2025, Hansoh Pharmaceutical Group (3692) is trading at a price of 29.20, with a previous close of 29.30. The stock has fluctuated within a day range of 28.75 to 29.75, while its 52-week range spans from 15.32 to 30.85.

What Is Hansoh Pharmaceutical Group (3692) Price Target According to Analysts?

The average 12-month price target for Hansoh Pharmaceutical Group is HKD28.52173866, with a high estimate of HKD38.27118644 and a low estimate of HKD23.17113177. 23 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Buy. The stock has an -2.32% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.